| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | WO2001049309A2 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049295A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | WO2001049287A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 07/12/2001 | WO2001049283A1 Preparations for the non-traumatic excision of a nail |
| 07/12/2001 | WO2001049252A2 Oil-in-water type cosmetic or dermatological preparations |
| 07/12/2001 | WO2001049250A2 Treatment of acne using lipoic acid |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2001004113A3 Process for the preparation of paroxetine and synthetic intermeditates thereof |
| 07/12/2001 | WO2000078928A3 Surface for cell culture |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000005223A3 Heterocyclic derivatives and their use as integrin inhibitors |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | US20010007866 Treatment of pruritus with vitamin d and analogs thereof |
| 07/12/2001 | US20010007674 Stimulate hair growth |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19962470A1 Verwendung von Chemotherapeutika Use of chemotherapeutic agents |
| 07/12/2001 | DE19960490A1 Regenerationsmittel Regenerant |
| 07/12/2001 | DE10061801A1 New compositions containing hydrophilic film former, water and urea useful for non-traumatic removal of fungally infected areas in finger- and toenails |
| 07/12/2001 | DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives |
| 07/12/2001 | DE10000210A1 Stable oil-in-water preparations which include a citrate ester, are useful, e.g., in care of skin and are stabilized by a very low density difference between the oil and aqueous phases |
| 07/12/2001 | CA2475413A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2475393A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396393A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395487A1 Composition for the treatment of damaged tissue |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2362453A1 Treatment of acne using lipoic acid |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114822A2 Indoles and tetrahydroisoquinolines containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/11/2001 | EP1114643A2 Herb containing ointment for the therapy of dermatologic diseases |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114052A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114046A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 07/11/2001 | EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 07/11/2001 | EP1114035A1 Quinazoline derivatives and pharmaceutical applications thereof |
| 07/11/2001 | EP1114029A1 Novel compounds |
| 07/11/2001 | EP1113798A1 Topical formulation of alkyl-, phenyl-pyridone |
| 07/11/2001 | EP0659080B1 Method for the treatment of hair loss |
| 07/11/2001 | CN1303384A Pyrrolo [1,2-a] pyrazine sPLA2 inhibitor |
| 07/11/2001 | CN1303380A Isothizole derivatives useful anticancer agents |
| 07/11/2001 | CN1303379A 2-Aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303368A 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303364A Aminocyclohexyl ether compounds and uses thereof |
| 07/11/2001 | CN1303296A Process of powder for bath from natural plants |
| 07/11/2001 | CN1303295A Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 07/11/2001 | CN1303282A Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin |
| 07/11/2001 | CN1303279A Topical transdermal treatments |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1302661A Medicinal composition containing aloe and its preparing process and application |
| 07/11/2001 | CN1302656A Veterinary medicine prepared from sophora seed and its preparing process |
| 07/11/2001 | CN1302654A Medicinal composition containing aloe and its preparing process and application |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302640A Cell repair |
| 07/11/2001 | CN1302626A Medical pill and liquid medicine for treating scald, burn and injury |
| 07/11/2001 | CN1302600A Series products containing Chinese soapherry extract |
| 07/11/2001 | CN1302599A Cosmetic composition containing N-ethoxycarbonyl-4-amino-phenol and arbutin or its derivative and/or ellagic acid or its derivative |
| 07/11/2001 | CN1068217C Traditional Chinese medicine for treating skin disease and veneral disease |
| 07/11/2001 | CN1068200C 9-cis-isotretinoin and use of its salt and ester medicine |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds. |
| 07/10/2001 | US6258802 Corticoid therapy |
| 07/10/2001 | US6258775 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258368 Porous, absorbent sheet impregnated with microbiocidal cleaning compound, anionic surfactant, acid, and water |
| 07/10/2001 | US6258365 Organosilicone gel compositions for personal care |
| 07/10/2001 | US6258355 Topically applying sphingomyelinase from lactic bacteria in sonicated cells; treating atopic eczema, dermatosis, or dermatitis |